Tellgen Corp Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Tellgen Corp cash flow conversion efficiency. Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tellgen Corp (2012–2025)

Cash flow conversion efficiency of Tellgen Corp from 2012 to 2025. This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300642 stock price for real-time trading data and today's change.

Tellgen Corp Cash Flow Conversion Ratio Explained

Tellgen Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tellgen Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency. Also see 300642 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Rechi Precision Co Ltd TW:4532	0.125x
Xunlei Ltd Adr NASDAQ:XNET	0.002x
Beijing HuaYuanYiTong Thermal Technology Co Ltd SHE:002893	0.080x
Daodaoquan Grain and Oil Co Ltd SHE:002852	0.260x
Ascencio (D) BR:ASCE	0.035x
Pharmicell KO:005690	0.080x
Eg Industries Bhd KLSE:8907	0.026x
Hotel Majestic Cannes PA:MLHMC	0.033x

Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2025. Review how much free cash does Tellgen Corp generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.48 Billion ≈ $216.63 Million	CN¥143.23 Million ≈ $20.96 Million	0.097x	-10.78%
2024-12-31	CN¥1.52 Billion ≈ $222.14 Million	CN¥164.62 Million ≈ $24.09 Million	0.108x	+31.75%
2023-12-31	CN¥1.54 Billion ≈ $224.72 Million	CN¥126.40 Million ≈ $18.50 Million	0.082x	-26.01%
2022-12-31	CN¥1.48 Billion ≈ $216.67 Million	CN¥164.72 Million ≈ $24.10 Million	0.111x	+88.02%
2021-12-31	CN¥1.40 Billion ≈ $204.32 Million	CN¥82.61 Million ≈ $12.09 Million	0.059x	-22.61%
2020-12-31	CN¥1.27 Billion ≈ $185.34 Million	CN¥96.83 Million ≈ $14.17 Million	0.076x	-48.90%
2019-12-31	CN¥1.17 Billion ≈ $171.01 Million	CN¥174.84 Million ≈ $25.59 Million	0.150x	-5.02%
2018-12-31	CN¥1.02 Billion ≈ $149.87 Million	CN¥161.32 Million ≈ $23.61 Million	0.158x	+33.13%
2017-12-31	CN¥895.86 Million ≈ $131.09 Million	CN¥106.00 Million ≈ $15.51 Million	0.118x	-65.30%
2016-12-31	CN¥288.65 Million ≈ $42.24 Million	CN¥98.42 Million ≈ $14.40 Million	0.341x	+1.41%
2015-12-31	CN¥192.33 Million ≈ $28.14 Million	CN¥64.67 Million ≈ $9.46 Million	0.336x	+7.97%
2014-12-31	CN¥131.05 Million ≈ $19.18 Million	CN¥40.81 Million ≈ $5.97 Million	0.311x	+12.41%
2013-12-31	CN¥95.04 Million ≈ $13.91 Million	CN¥26.33 Million ≈ $3.85 Million	0.277x	+193.02%
2012-12-31	CN¥72.47 Million ≈ $10.60 Million	CN¥6.85 Million ≈ $1.00 Million	0.095x	--

About Tellgen Corp

SHE:300642 China Medical Devices

Market Cap

$362.12 Million

CN¥2.47 Billion CNY

Market Cap Rank

#13587 Global

#3991 in China

Share Price

CN¥15.25

Change (1 day)

-5.22%

52-Week Range

CN¥11.22 - CN¥22.54

All Time High

CN¥46.24